This report from Life Science Intelligence provides the latest market data for the Global Neurovascular Interventional Devices for Hemorrhagic Stroke Market. Information covered by this report includes:
This report covers the impact of COVID-19 on the neurovascular interventional devices for hemorrhagic stroke market, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and others. The report provides insights into trends, drivers, and limiters of the neurovascular devices for hemorrhagic stroke market, as well as highlights potential opportunities.
Abbott
Boston Scientific
Cerenovus/J&J
Cordis Cardinal Health
Evasc
Microport
Microvention/Terumo
Micrus
Penumbra
Target/Stryker
Trusted By The Companies Pioneering What’s Next
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy